健康元 (600380)

Joincare Pharmaceutical Group Industry Co., Ltd.

ASH

Tags

AI HealthcareDeepSeekSSE 380 IndexCSI Share Buyback IndexArtificial Intelligence (AI)Weight Loss DrugsInnovation 100 IndexInnovative DrugsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareSynthetic BiologyContains Global Depository Receipts (GDR)Guozheng Value IndexPet EconomySmall Cap ValueGuangdong-Hong Kong-Macao Greater Bay AreaHigh-Performing StocksTencent ConceptFree Cash FlowMargin Trading and Securities LendingAssisted ReproductionNorthbound Connect Heavy Positions

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 182945.34
  • Circulating A-Shares(W): 182945.34
  • Earnings Per Share(RMB): 0.6000
  • Net Assets Per Share(RMB): 8.1262
  • Operating Revenue(W RMB): 1147780.69
  • Total Profit(W RMB): 285273.56
  • **Net Profit Attributable to Parent(W RMB) **: 109121.41
  • Net Profit Growth Rate(%): -1.83
  • Weighted Return on Equity(%): 7.4600
  • Operating Cash Flow Per Share(RMB): 1.6410
  • Undistributed Profit Per Share(RMB): 6.1297
  • Capital Reserve Per Share(RMB): 0.5604

2. Main Business

The main business covers:

  • Chinese patent medicine
  • Oral liquid
  • Tablets
  • Capsules
  • Granules
  • Hormone tablets

3. Company Basic Information

  • Company Name: Joincare Pharmaceutical Group Industry Co., Ltd.
  • Listing Date: 2001-06-08
  • Industry: Pharmaceutical Manufacturing
  • Address: 17 Langshan Road, North Zone, High-tech Park, Nanshan District, Shenzhen, Guangdong Province, Joincare Pharmaceutical Group Building
  • Website: https://www.joincare.com
  • Company Profile: The company was transformed from Shenzhen Taita Pharmaceutical Co., Ltd. In January 1994, it was renamed Shenzhen Taita Health Food Co., Ltd. In January 1995, the registered capital increased from USD 550,000 to RMB 30 million, and it was renamed Shenzhen Taita Pharmaceutical Co., Ltd. On September 16, 1999, it was transformed into a joint stock company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shenzhen Baiyeyuan Investment Co., Ltd. General Legal Person 89565.37 48.96
2 Hong Xin Hang Limited General Legal Person 3592.97 1.96
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 3420.60 1.87
4 CSI 500 Exchange Traded Fund Fund 1593.81 0.87
5 Ruizhong Life Insurance Co., Ltd. - Proprietary Funds Insurance 1273.92 0.70
6 Yinhua CSI Innovative Drug Industry ETF Fund 1068.29 0.58
7 Joincare Pharmaceutical Group Industry Co., Ltd. - Medium and Long-term Career Partner Shareholding Plan (Phase 3) Asset Management Plan 937.04 0.51
8 GTJA Allianz Funds - China Pacific Life Insurance Co., Ltd. - Participating Insurance - GTJA Allianz Funds China Pacific Life Insurance Equity Relative Return (Policy Bonus) Single Asset Management Plan Asset Management Plan 795.72 0.43
9 GTJA Allianz Derson Small Cap Selected Securities Investment Fund Fund 424.84 0.23
10 GTJA Allianz Value Selection Mixed Securities Investment Fund Fund 53.30 0.03

5. Concept Sectors

  • Guangdong-Hong Kong-Macao Greater Bay Area
  • Artificial Intelligence
  • Tencent Concept
  • GDR Included
  • Assisted Reproduction
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology
  • Pet Economy
  • DeepSeek
  • AI Healthcare

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information